![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1410025
¼¼°è ÀüÀÚ Ã³¹æÀü ½ÃÀå ¿¹Ãø(2023-2028³â)E-Prescribing Market - Forecasts from 2023 to 2028 |
ÀüÀÚ Ã³¹æÀü ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 17.49%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀüÀÚ Ã³¹æÀü ½ÃÀåÀÇ ¼ºÀåÀº ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖÀ¸¸ç, À̸¥ ¹ã¿¡ ±×·¸°Ô µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áøº¸µÈ ÀÇ·á ¼ºñ½º Çõ½ÅÀÇ ÀÌ¿ë È®´ë, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)À» Áö¿øÇÏ´Â Á¤ºÎÀÇ ½Ã»ê, ¾àÁ¦ÀÇ ¾ÈÀü¼º°ú ȯÀÚÀÇ ¼º°ú¿¡ ÀÓÇÏ´Â °Í¿¡ ´ëÇÑ °¥¸ÁÀÌ ÀÌ ¹ßÀüÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ Ã³¹æÀü ½ÃÀå ±Ô¸ð´Â ÀüÀÚ Ã³¹æ ½Ã½ºÅÛ ¹× ¼Ö·ç¼Ç¿¡ ´ëÇÑ °Ç° °ü¸® Á¶Á÷ÀÇ ¿ä±¸¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÀüÀÚ Ã³¹æÀü ½ÃÀå Á¡À¯À²Àº Å©¸ç, ÀÌ·Î ÀÎÇØ E-Recommending ½ÃÀåÀÇ °æÀï·Â°ú ¿ªµ¿¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ¼½ÅͰ¡ µðÁöÅÐ º¯ÇõÀ» ¹Þ¾ÆµéÀÌ´Â °¡¿îµ¥, ÀüÀÚ Ã³¹æÀü ½ÃÀåÀÇ ¼ºÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå°ú Çõ½ÅÀÇ Å¼¼¸¦ Á¤µ·Çϰí ÀÖ½À´Ï´Ù.
÷´Ü ÀÇ·á ¼ºñ½º ¼Ö·ç¼ÇÀÇ È°¿ë È®´ë·Î ÀüÀÚ Ã³¹æÀü ½ÃÀå ±Ô¸ð´Â Å« Àüȯ±â¿Í º¯È¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ Ã³¹æÀüÀº ÀÇ·á ¼ºñ½º Àü¹®°¡¿Í ¾à±¹ »çÀÌ¿¡¼ Ä¡·áÁ¦ ÁÖ¹®À» ÀüÀÚÀûÀ¸·Î Àü´ÞÇϰí Àü´ÞÇÏ´Â ½Ã½ºÅÛÀÔ´Ï´Ù. ÀüÀÚ Ã³¹æÀüÀº ±âÁ¸ Á¾ÀÌ ±â¹Ý ¼Ö·ç¼ÇÀÇ Çʿ伺À» ¾ø¾Ö°í ¾à¹°ÀÇ Á¤È®¼ºÀ» ³ôÀ̰í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ½Å¼ÓÇÏ°Ô ÀÛ¾÷ÇÏ´Â ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù.
ÀüÀÚ Ã³¹æÀü ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ¼ºñ½º Çùȸ¿Í °ø±Þ¾÷ü°¡ Á¾ÀÌ ±â¹Ý ¼Ö·ç¼Ç¿¡¼ ÀüÀÚ ÇÁ·¹ÀÓ¿öÅ©·ÎÀÇ Àüȯ¿¡ ÀÌÁ¡À» ´À³¢°í Àֱ⠶§¹®¿¡ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ Ã³¹æÀüÀº ÀÇ·á ¼ºñ½ºÀÇ ÀüÀÚÈ¿¡ ÀÖ¾î¼ ±âº»ÀûÀÎ ¿ªÇÒÀ» ´ã´çÇÒ Áغñ°¡ µÇ¾î ÀÖ¾î, ÇコÄɾ ÀÌÇØÇϰí, Ä¡·á ¹Ì½º¸¦ ¾ïÁ¦Çϰí, ÇコÄɾîÀÇ ¼÷·Ãµµ¸¦ Çâ»ó½Ãų °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.
ÀüÀÚ Ã³¹æÀü ¼Ö·ç¼ÇÀº ÇコÄɾîÀÇ µðÁöÅÐÈ ±¸»ó°ú ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ º¸±Þ¿¡ µû¶ó ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ¾÷¹« ÇÁ·Î¼¼½º¸¦ ¿øÈ°ÇÏ°Ô ÇÏ°í °æ¿µÁøÀÇ »ý»ê¼ºÀ» ´õ¿í Çâ»ó½Ã۰íÀÚ ÇÏ´Â °¥¸ÁÀÌ ÀÌ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
ÀüÀÚ Ã³¹æÀü ÇÁ·¹ÀÓ¿öÅ©´Â Ã¥»ó ÀÛ¾÷À» ¾ø¾Ö°í ¾à¹°ÀÇ ½ÇÆÐ¸¦ ÁÙÀ̰í Ä¡·áÁֱ⸦ °¡¼ÓÈÇÔÀ¸·Î½á Çö±Ý°ú ½Ã°£À» º¸ÀåÇÕ´Ï´Ù. ÀÌ·Î ÀÎÇØ ÀÇ·á °ø±ÞÀÚ´Â ÀüÀÚ Ã³¹æÀüÀÇ Áøº¸¸¦ º¸³» ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ°í ¾÷¹«¸¦ Çâ»ó½Ãŵ´Ï´Ù.
´Ù±â´É ¿ëµµ ¹× Ŭ¶ó¿ìµå ±â¹Ý ½ºÅ×ÀÌÁö¿Í °°Àº ÀÇ·á Çõ½ÅÀÇ ÃßÁøÀº ÀüÀÚ Ã³¹æÀü ½ÃÀåÀ» ÀüÁø½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ±âÁ¸ ÀÇ·á ¼ºñ½º ÇÁ·¹ÀÓ¿öÅ©¿ÍÀÇ ÀϰüµÈ °ü·Ã¼º, ´õ¿í ¹ßÀüµÈ °³¹æ¼º, ÀÇ·á ¼ºñ½º Àü¹®°¡ ¹× ȯÀÚ ¸ðµÎ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼Ö·ç¼Ç µ¥ÀÌÅ͸¦ °í·ÁÇÕ´Ï´Ù.
ÀüÀÚ Ã³¹æÀü ½ÃÀåÀº Á¦Ç°, Á¦°ø ÇüÅÂ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù. Á¦Ç°Àº ¼ºñ½º¿Í ¼Ö·ç¼ÇÀ¸·Î ³ª´¹´Ï´Ù. °ÔÀç ÇüÅ´ ¶ÇÇÑ ¿ÂÇÁ·¹¹Ì½º, Ŭ¶ó¿ìµå ±â¹Ý, À¥ ±â¹ÝÀ¸·Î ±¸ºÐµË´Ï´Ù.
ºÏ¹Ì´Â ÀüÀÚ Ã³¹æÀü ½ÃÀåÀÇ ¼±µÎ ÁÖÀÚÀ̸ç ÀüÀÚ Ã³¹æÀü ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀÌÁ¡¿¡´Â ¿©·¯ °¡Áö ÀÌÀ¯°¡ ÀÖ½À´Ï´Ù. ù°, È®¸³µÈ ÇコÄɾî ÀÎÇÁ¶ó¿Í Çö´ëÀûÀÎ ÇコÄɾî IT ½Ã½ºÅÛÀº ÀüÀÚ Ã³¹æÀü ¼Ö·ç¼ÇÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. µÑ°, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°ú µðÁöÅРó¹æÀü »ç¿ëÀ» Àå·ÁÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¹ý·üÀº ¾÷°è È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ »çÀÌ¿¡¼ ÀüÀÚ Ã³¹æÀüÀÇ ÀåÁ¡ÀÌ ³Î¸® Àνĵǰí ÀÖ´Â °Íµµ ºÏ¹Ì¿¡¼ ÀüÀÚ Ã³¹æÀüÀÌ ³Î¸® ¹Þ¾Æµé¿©Áö´Â ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ÁÖ¿ä °æÀï»ç¿Í Á¦ÈÞ ¹× ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ÀüÀÚ Ã³¹æÀü ½ÃÀå¿¡¼ ºÏ¹Ì ½ÃÀå ÁöÀ§°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
2023³â 6¿ù Telecare´Â È£ÁÖ ÃÖÃÊÀÇ µ¶¸³Çü ÀüÀÚ Ã³¹æÀü Ç÷§ÆûÀÎ RxPad¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº ÀÇ·á Á¾»çÀÚ°¡ Áø·á °ü¸® ¼ÒÇÁÆ®¿þ¾î¿¡ ÀÔ·ÂÇÏÁö ¾Ê°í ó¹æÀüÀ» ÀÛ¼ºÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ȯÀÚÀÇ Ã³¹æÀüÀ» ã¾Æº¸°í ÆíÁýÇÒ ¼ö ÀÖ´Â ¾×¼¼½º¸¦ ´õ¿í Çâ»ó½Ãŵ´Ï´Ù. 2023³â 1¿ù¿¡´Â »óÈ£ ¿î¿ë¼º Ç÷§Æû ¹× ÀÇ·á Á¤º¸ ³×Æ®¿öÅ©(HIN)ÀÇ ¼±µÎ ±â¾÷ÀÎ Health GorillaÀÇ »õ·Î¿î ¼Ö·ç¼ÇÀÎ Pharmacy Data°¡ µîÀåÇÏ¿© ´ëºÎºÐÀÇ ÁÖ¿ä ¾à±¹ÀÇ Á¾ÇÕÀûÀΠó¹æ ºÐ¼® µ¥ÀÌÅÍ¿¡ ½±°Ô ¿¡ ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. DrFirstÀÇ MedHx Àα¸ À§Çè °ü¸®(PRM) ½Ã½ºÅÛÀº Pharmacy DataÀÇ ¿øµ¿·ÂÀ¸·Î ó¹æ µ¥ÀÌÅÍ, ¾à±¹ Á¦Çü µ¥ÀÌÅÍ, ¾à±¹ ÇýÅà °ü¸® û±¸ µî Áö¿ª ¹× ±¹³» µ¥ÀÌÅÍ ¼Ò½º¿¡¼ Áߺ¹ Á¦°ÅµÈ ó¹æ ³»¿ªÀ» Á¦°øÇÕ´Ï´Ù.
The E-Prescribing market is estimated to grow at a CAGR of 17.49% during the forecast period.
The E-Prescribing market growth is expanding quickly and is supposed to do so sooner rather than later. The expanded use of advanced medical services innovations, government estimates supporting electronic health records (EHRs), and the craving to work on drug security and patient results are driving this development. The E-Prescribing market size is influenced by healthcare organizations' requirements for E-Prescribing systems and solutions. The market's significant participants have huge E-Prescribing market shares, which adds to the general competitiveness and dynamism of the E-Recommending market. As the healthcare sector embraces digital transformation, the e-prescription market growth is poised for ongoing growth and innovation.
Due to the expanded utilization of advanced medical services solutions, the E-Prescribing market size is seeing a significant turn of events and change. The course of electronically delivering and conveying remedy orders between medical services professionals and drug stores is known as e-prescribing. It takes out the requirement for customary paper-based solutions, bringing about a few benefits like expanded drug precision, more noteworthy patient security, and quicker tasks.
The E-Prescribing market growth is growing quickly as medical services associations and suppliers see the advantages of moving from paper-based solutions to electronic frameworks. E-prescribing is ready to assume a basic part in the computerized unrest of medical services, with the possibility to work on understanding healthcare, limit remedy slip-ups, and increment by and large healthcare proficiency.
E-prescribing solutions are in high demand as healthcare digitalization initiatives and electronic health records (EHRs) gain traction. The longing to increase patient security, smooth out work processes, and further develop drug the executive's productivity is driving this reception.
E-prescribing frameworks set aside cash and time by disposing of desk work, decreasing drug botches, and speeding up the remedy cycle. This spurs medical care suppliers to send E-Prescribing advances to improve patient results and upgrade their tasks.
Propels in healthcare innovation, including versatile applications and cloud-based stages, help to drive the E-Prescribing market forward. These innovations take into consideration consistent association with existing medical services frameworks, further developed openness, and constant solution data for both medical services experts and patients.
The market for e-prescribing is segmented by product, delivery mode, end-user, and geography. The product is further segmented into services and solutions. Delivery mode is further segmented into on-premises, cloud-based, and web-based.
North America is the market leader in E-Prescribing, with a significant e-prescribing market share. Several reasons contribute to the region's prominence. For starters, the availability of established healthcare infrastructure and modern healthcare IT systems has aided E-Prescribing solution uptake. Second, government initiatives and legislation encouraging the use of electronic health records (EHRs) and digital prescriptions have spurred industry expansion. Furthermore, a great awareness of the benefits of E-Prescribing among healthcare practitioners and patients has helped to its broad acceptance in North America. Major competitors in the area, as well as alliances and partnerships, have enhanced North America's market position in the E-Prescribing market.